Acetylcholine iodide

CAS No. 2260-50-6

Acetylcholine iodide( Acetylcholine iodide, AI3-51677 )

Catalog No. M18267 CAS No. 2260-50-6

Acetylcholine iodide is a neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
50MG 29 In Stock
100MG 38 In Stock
200MG Get Quote In Stock
500MG 86 In Stock
1G 126 In Stock

Biological Information

  • Product Name
    Acetylcholine iodide
  • Note
    Research use only, not for human use.
  • Brief Description
    Acetylcholine iodide is a neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.
  • Description
    Acetylcholine iodide is an endogenous neurotransmitter at cholinergic synapses. Acetylcholine iodide amplifies the action potential of the sarcolemma thereby inducing muscle contractions.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Acetylcholine iodide, AI3-51677
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    2260-50-6
  • Formula Weight
    273.11
  • Molecular Formula
    C7H16NO2·I
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : ≥ 100 mg/mL (366.15 mM))
  • SMILES
    CC(=O)OCC[N+](C)(C)C.[I-]
  • Chemical Name
    (2-Acetoxyethyl)trimethylammonium iodide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • RF-amide peptide, Dr...

    RF-amide peptide, Drosophila

  • Hsp Heat shock prote...

    Hsp Heat shock protein (3-13)

  • DB818

    DB818 is a synthetic Homeobox A9 (HOXA9) inhibitor and can be used for research on the treatment of acute myeloid leukaemia associated with HOXA9 overexpression.